In patients with locally advanced rectal cancer who receive neoadjuvant therapy, radiation dose intensification improves pathologic complete response but leads to a small increase in acute toxicities.

ARLINGTON, Va., November 25, 2024 — The American Society for Radiation Oncology (ASTRO) issued today an updated clinical guideline for physicians who use radiation therapy to treat patients with ...

City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.S. News & World ...

Radiation-related bowel toxicity among real-world patients was lower with use of the rectal spacer. Use of a hydrogel rectal spacer reduces the incidence of bowel disorders and related procedures over ...

The American Society for Radiation Oncology (ASTRO) issued today an updated clinical guideline for physicians who use radiation therapy to treat patients with locally advanced rectal cancer. This ...

MRI can predict the risk of rectal cancer reccurring or spreading for patients who have undergone chemotherapy and radiation, new research indicates. Magnetic resonance imaging (MRI) can spare many ...

Patients with secondary rectal cancer after prostate cancer radiation therapy may have worse survival than patients with primary rectal cancer. Secondary rectal cancer after prostate cancer radiation ...

Our Care Advisors will connect you with the best healthcare provider for your needs. Finding the right cancer care team can be stressful. Your team of rectal cancer experts will ask about your ...

According to a meta-analysis of randomized clinical trials (RCTs), pathologic complete response (pCR) was not associated with overall or disease-free survival in patients with rectal cancer, ...